Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Disease Research (RDR) is an independent clinical research site network 100% dedicated to conducting clinical trials for rare and orphan diseases. Founded in 2017 by pediatric neurologist Dr. Han Phan, the company operates specialized facilities in Georgia, North Carolina, Florida, and New Jersey. RDR focuses on accelerating the development of safe and effective treatments for conditions such as Duchenne muscular dystrophy, spinal muscular atrophy, and various genetic disorders. The organization provides patients with access to innovative investigational therapies while offering sponsors high-quality data and specialized expertise in rare disease populations. In 2023, RDR expanded its footprint by opening a new site in Hillsborough, North Carolina, with support from Parent Project Muscular Dystrophy (PPMD).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rare Disease Research NC.